Intermediate for Tofacitinib. Tofacitinib (trade name Xeljanz, Jakvinus) is a janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib has been approved by the U.S Food and Drug Administration in November 2012.


Product Name:                  7H-Pyrrolo[2,3-d]pyrimidin-4-ol

Synonyms:                         N/A

CAS Number:                     3680-71-5

Molecular Weight:            135.125

Molecular Formula:          C6H5N3O

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=c1nc[nH]c2c1cc[nH]2

  • $138.00
  • Ex Tax: $138.00

Available Options